Live Events

 
 
October
21
Sunday
5:45 AM

Migraine

Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?

Atlanta, GA

Stewart J. Tepper, MD, FAHS
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

October
22
Monday
6:00 PM

EGFR-Mutant NSCLC

Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do

Chicago, IL

Lynette M. Sholl, MD
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts

October
22
Monday
6:45 PM
October
23
Tuesday
1:00 PM

Hepatitis C virus

Addressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education

Hagerstown, MD

Mark S. Sulkowski, MD
Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

October
23
Tuesday
6:00 PM

Immuno-Oncology Biomarkers

The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies

Chicago, IL

Robert Anders, MD, PhD
Johns Hopkins University
The Bloomberg~Kimmel Institute for Cancer Immunotherapy
Baltimore, Maryland

October
24
Wednesday
6:00 AM

Immuno-Oncology

Incorporating Cancer Immunotherapies Into the Oncology Treatment Arsenal in Managed Care Settings: Navigating the Complexities of Value Assessment & Cost Optimization in the Era of Immuno-Oncology

Orlando, Florida

Michael B. Atkins, MD
Georgetown-Lombardi Comprehensive Cancer Center
Georgetown University School of Medicine
Washington, District of Columbia

James T. Kenney, RPh, MBA
Harvard Pilgrim Health Care
Waltham, Massachusetts

November
10
Saturday
7:30 PM

Hepatocellular Carcinoma

Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes

San Francisco, CA

Jorge A. Marrero, MD, MS
UT Southwestern Medical Center
Dallas, Texas

November
11
Sunday
6:00 AM

Cardiology

Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How Low Do We Go?

Chicago, IL

Marc S. Sabatine, MD, MPH
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts

November
15
Thursday
7:00 PM

Sarcoma

The Promise of New Concepts and Innovative Therapy in Advanced Sarcoma: From Established Targets to TRK Inhibition and Beyond

Rome, Italy

George D. Demetri, MD
Dana-Farber Cancer Institute
Ludwig Center at Harvard
Harvard Medical School
Boston, Massachusetts

November
17
Saturday
11:45 AM

Glioblastoma

Transforming Glioblastoma Management: A MasterClass on Evaluating Newer and Emerging Options in the Precision Medicine and Person-Centered Care Era

New Orleans, Louisiana

Steven Brem, MD
Penn Brain Tumor Center
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

November
29
Thursday
11:20 AM

Bladder Cancer

Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes

Phoenix, Arizona

Arjun Balar, MD
Laura and Isaac Perlmutter Cancer Center
NYU Langone Health
New York, New York

November
30
Friday
7:00 AM

Lymphoma

Exploring the Present and Future of BTK Inhibition in B-Cell Malignancies: Expert Insights on Practical Implications for Patient Management

San Diego, California

Andre H. Goy, MD
John Theurer Cancer Center
Seton Hall – Hackensack Meridian School of Medicine
Hackensack, New Jersey

October
23
Tuesday
6:30 PM

Immuno-Oncology Biomarkers

The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies

Robert Anders, MD, PhD
Johns Hopkins University
The Bloomberg~Kimmel Institute for Cancer Immunotherapy
Baltimore, Maryland

November
14
Wednesday
3:00 PM
7:00 PM
November
15
Thursday
7:00 PM

Tardive Dyskinesia

Improving Long-Term Outcomes in Patients With Tardive Dyskinesia: Examining the Impact of New Therapeutic Options

Joseph McEvoy, MD
Medical College of Georgia
Augusta, Georgia

October
13
Saturday
6:00 AM

Lung Cancer

The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care

New York, NY

Naiyer Rizvi, MD
Columbia University Medical Center
New York, New York

Benny Weksler, MBA, MD
University of Tennessee Health Science Center
Methodist University Hospital
Memphis, Tennessee

October
8
Monday
5:45 AM

Asthma

A MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies

San Antonio, Texas

Jonathan Corren, MD
David Geffen School of Medicine at UCLA
Los Angeles, California

October
4
Thursday
6:00 AM

Immuno-Oncology Biomarkers

Advances and Challenges in Refining the Use of Cancer Immunotherapies Through Biomarker Testing:
Practical Guidance for Pathologists on the Front Lines of the Immuno-Oncology Revolution

Baltimore, MD

Kurt Schalper, MD, PhD
Yale School of Medicine
Yale Cancer Center
New Haven, Connecticut

Edward B. Garon, MD, MS
UCLA's Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
Los Angeles, California

October
3
Wednesday
11:10 AM

EGFR-Mutant NSCLC

Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists

Baltimore, MD

Anjali Saqi, MD, MBA
Columbia University Medical Center
New-York Presbyterian Hospital
New York, New York

Pathology Specialist

Geoffrey R. Oxnard, MD
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Oncology Specialist
October
2
Tuesday
6:00 AM

Lung Cancer

Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice

New York, NY

Edward B. Garon, MD, MS
UCLA's Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
Los Angeles, California

September
30
Sunday
6:00 PM

Oncologic Emergencies

Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy–Related Adverse Effects in the Emergency Department

San Diego, California

Daniel Pallin, MD, MPH
Harvard Medical School
Brigham and Women’s Hospital
Boston, Massachusetts

September
26
Wed
3:00 PM

Hemophilia A

Treatment Innovation in Hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice

Mark T. Reding, MD
University of Minnesota
Minneapolis, Minnesota

September
22
Saturday
11:50 AM

Chronic Pain

The Role of Abuse-Deterrent Therapies in a Multimodal Approach to Chronic Pain Management—Improving Outcomes and Averting Medication Misuse

Atlanta, GA

Sanford M. Silverman, MD
Silver Lining Medical Consultants
Coastal Pain Medicine
Pompano Beach, Florida

Florida Society Interventional Pain Physicians
Broward County Medical Association
American Society Interventional Pain Physicians
Florida Society Interventional Pain Physicians
Boca Raton, Florida

September
15
Saturday
6:30 AM

B‑Cell NHL

Integrating BTK Inhibitors Into the Management of B‑Cell Malignancies: How Is Evidence Driving Patient Care?

Houston, TX

Michael Wang, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

September
7
Friday
7:00 PM

Lymphoma

Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL

Chicago, IL

Nathan H. Fowler, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

July
9
Monday
5:30 PM

Hepatitis C virus

Addressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education

Baltimore, MD

Mark S. Sulkowski, MD
Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

June
3
Sunday
6:30 PM

Colorectal & Gastrointestinal Cancers

The Advent of Immunotherapy in Gastrointestinal Cancers: MasterClass and Practicum on Checkpoint Inhibition and Biomarkers in Colorectal and Gastric Tumors

Chicago, IL

Eric Van Cutsem, MD, PhD
University Hospitals Leuven
Leuven, Belgium

June
3
Sunday
6:30 PM

Melanoma

Tracing the Arc of Immunotherapy in Melanoma: Insights on the Current Role and Cutting-Edge Uses of Checkpoint Inhibitors for Patient Care

Chicago, IL

Omid Hamid, MD
The Angeles Clinic and Research Institute
Cedars Sinai Medical Care Foundation
Los Angeles, California

June
2
Saturday
6:30 PM

Pancreatic Cancer

Rethinking Successful Care for Pancreatic Cancer: Therapeutic Sequencing, Innovative Strategies, and Patient Perspectives on Disease Management

Chicago, IL

Johanna C. Bendell, MD
Sarah Cannon Research Institute
Nashville, Tennessee

June
2
Saturday
6:30 PM

TRK Fusion-Positive Cancers

Making the TRK to Precision Medicine in Cancer: The Promise of Targeting TRK Fusions in Lung, Breast, GI, and Other Tumors

Chicago, IL

George D. Demetri, MD
Dana-Farber Cancer Institute
Ludwig Center at Harvard
Harvard Medical School
Boston, Massachusetts

June
2
Saturday
6:30 PM

Multiple Myeloma

A Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat

Chicago, IL

Robert Z. Orlowski, MD, PhD
The University of Texas MD Anderson Cancer Center
Houston, Texas

June
2
Saturday
6:30 PM

Lung Cancer

Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies

Chicago, IL

Edward B. Garon, MD, MS
UCLA's Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
Los Angeles, California

June
1
Friday
6:30PM

Renal Cell Carcinoma

Rethinking the Management of Advanced RCC in an Evolving Therapeutic Landscape: Focus on New Options and Patient-Centered Treatment Decisions

Chicago, IL

David F. McDermott, MD
Beth Israel Deaconess Medical Center
Dana-Farber Harvard Cancer Center
Kidney Cancer Program
Harvard Medical School
Boston, Massachusetts

June
1
Friday
6:30 PM

Non-Hodgkin Lymphoma

The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma

Chicago, IL

John P. Leonard, MD
Weill Cornell Medicine
New York, New York

June
1
Friday
6:30 PM

Prostate Cancer

Newest Advances and Strategies in Prostate Cancer: Science and Stories on the Evolving Treatment Landscape and Implications for Patient Care

Chicago, IL

Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

June
1
Friday
6:30 PM

Acute myeloid leukemia

Making Therapeutic Choices for Diverse AML Populations: Exploring New Science, More Effective Treatment Options, and Impact on Patient Care

Chicago, IL

Farhad Ravandi, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

May
30
Wed
3:00 PM

Multiple Sclerosis

Navigating the Expanding Sphingosine-1-Phosphate Receptor Modulator Armamentarium for Multiple Sclerosis Management: Greater Opportunities for Patients With MS

Nashville, TN

Bruce Cree, MD, PhD, MAS
UCSF Multiple Sclerosis Center
San Francisco, California

May
22
Tuesday
6:30 PM

ILD

Win the Room! Updates in Interstitial Lung Disease: Making Strides in Accurate Diagnosis and Optimized Treatment

San Diego, CA

Lisa H. Lancaster, MD
Vanderbilt University Medical Center
Nashville, Tennessee

May
22
Tuesday
6:30 PM

Pulmonary Hypertension

COMPETE AND WIN! Pulmonary Hypertension at the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies

San Diego, CA

Nick H. Kim, MD
University of California San Diego
La Jolla, California

May
19
Saturday
6:00 PM

Prostate Cancer

Science and Stories: Navigating the Prostate Cancer Landscape
Urologists at the Intersection of Emerging Evidence and Patient Centric Care

San Francisco, CA

Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

May
18
Friday
5:30 AM

Pancreatic Cancer

The Pancreatic Cancer Journey: Oncology Nurses Paving the Path to Patient-Centric Care

Washington, DC

Gayle Jameson, MSN, ACNP-BC, AOCN
Honor Health Research Institute
Scottsdale, Arizona

April
30
Monday
6:15 AM

Neovascular AMD

Updates in Neovascular Age-Related Macular Degeneration: Improving Detection, Reducing the Burden of Treatment, and Optimizing Visual Outcomes

Honolulu, HI

Pravin U. Dugel, MD
Retinal Consultants of Arizona LTD
Retinal Research Institute LLC
Phoenix Eye Institute
Banner University Medical Center
Phoenix, Arizona
USC Roski Eye Institute
Keck School of Medicine
University of Southern California
Los Angeles, California

April
26
Thursday
12:00 PM

Interstitial Lung Disease

Achieving Early and Accurate Diagnosis of Interstitial Lung Disease

Washington, DC

Jonathan G. Goldin, MD, PhD
UCLA Medical Center, Santa Monica
Santa Monica, California

David J. Lederer, MD, MS
Columbia University Medical Center
New York, New York

April
10
Tuesday
5:30PM

Phenylketonuria

The Evolving Role of Current and Novel Therapies in Improving Outcomes in Adults With PKU

Charlotte, NC

Barbara K. Burton, MD
Northwestern University Feinberg School of Medicine
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois

Nicola Longo, MD, PhD
University of Utah
Salt Lake City, Utah

March
19
Monday
11:30 AM

Hepatocellular Carcinoma

At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma
Preparing for the Next Evolution in Multimodal Treatment

Los Angeles, CA

Riccardo Lencioni, MD, FSIR, EBIR
University of Pisa School of Medicine
Pisa, Italy

March
19
Monday
12:00 PM

Hepatocellular Carcinoma

At the Intersection of Local and Systemic Therapy in the Management of Hepatocellular Carcinoma
Preparing for the Next Evolution in Multimodal Treatment

Webcast

Riccardo Lencioni, MD, FSIR, EBIR
University of Pisa School of Medicine
Pisa, Italy

February
27
Tuesday
3:00PM
7:00PM

Asthma

Personalized Care Throughout the Journey of Patients With Asthma: Optimizing Inhaled and Targeted Treatment

Webcast

David A. Beuther, MD, FCCP
National Jewish Health
Denver, Colorado

Michael E. Wechsler, MD
NJH Cohen Family Asthma Institute
National Jewish Health
Denver, Colorado

February
24
Saturday
12:00PM

Graft-Versus-Host Disease

New Thinking on GVHD Management in HSCT Recipients: Focus on Underlying Immunology and Innovative Therapeutics

Salt Lake City

David Miklos, MD, PhD
Stanford University
Stanford, California

February
24
Saturday
6:30AM

Hodgkin Lymphoma

Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings

Salt Lake City

Anas Younes, MD
Memorial Sloan Kettering Cancer Center
New York, New York

February
23
Friday
12:00 PM

Acute Myeloid Leukemia

Novel Induction Options in AML: Assessing the Implications for HCT-Eligible Patients

Salt Lake City

Jorge E. Cortes
The University of Texas MD Anderson Cancer Center
Houston, Texas

February
22
Thursday
12:00PM

Myeloma

Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT

Salt Lake City

Paul Richardson, MD
Harvard Medical School
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

February
22
Thursday
6:30 AM

CAR-T Cell Therapy

Realizing the Promise of CAR-T Cell Therapy for Leukemia and Lymphoma

Salt Lake City

Stephan A. Grupp, MD, PhD
University of Pennsylvania Perelman School of Medicine
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania

February
21
Wed
12:00 PM

Hematopoietic cell transplantation

Refining the Management of CMV in HCT Recipients: What Does the Future Hold?

Salt Lake City

Francisco M. Marty, MD
Harvard Medical School
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Boston Massachusetts

February
14
Wed
6:00 PM

Head and Neck Cancer

Solving the Multimodal Puzzle of Head & Neck Cancer in the Immunotherapy Era: How Evidence is Driving Practice Changes

Scottsdale, AZ

Ezra Cohen, MD, FRCPC, FASCO
UC San Diego
San Diego Center for Precision Immunotherapy
UC San Diego Moores Cancer Center
La Jolla, California

February
14
Wed
6:30 PM

Head and Neck Cancer

Solving the Multimodal Puzzle of Head & Neck Cancer in the Immunotherapy Era: How Evidence is Driving Practice Changes

Webcast

Ezra Cohen, MD, FRCPC, FASCO
UC San Diego
San Diego Center for Precision Immunotherapy
UC San Diego Moores Cancer Center
La Jolla, California

February
8
Thursday
6:15PM

Genitourinary Cancers

Strengthening Our Grip on Immuno-Oncology in Genitourinary Cancers: Understanding Science Through Stories

San Francisco

Jonathan E. Rosenberg, MD
Memorial Sloan Kettering Cancer Institute
New York, New York

February
8
Thursday
6:15PM

Genitourinary Cancers

A Master Class on Applying Newer Therapies for Renal Cell Carcinoma: Meeting Real Challenges Through the Advanced Disease Continuum

San Francisco

David F. McDermott, MD
Beth Israel Deaconess Medical Center
Dana-Farber Harvard Cancer Center Kidney Cancer Program
Harvard Medical School
Boston, Massachusetts

January
30
Tuesday
3:00PM

Pneumococcal Vaccination

RISE: Raising Immunization RateS for Pneumococcal DiseasE in Adults

Webcast

Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP
Summa Health
Akron, Ohio
Northeast Ohio Medical University
Rootstown, Ohio

January
25
Thursday
6:30PM
January
25
Thursday
7:00PM
January
19
Friday
6:30PM

Pancreatic Cancer

The Quest to Win Through Science in Pancreatic Cancer: From Sequencing Current Options to Testing Novel Approaches

San Francisco

Andrew H. Ko, MD
Helen Diller Family Comprehensive Cancer Center
University of California San Francisco
San Francisco, California

January
18
Thursday
6:30PM

Oncology

New Options, Emerging Combinations in Advanced Hepatocellular Carcinoma: Are Management Approaches Poised for Transformation?

San Francisco

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
New York, New York

December
8
Friday
6:00PM

Hemophilia

Illuminating the Role of Shared Decision-Making as the Hemophilia A Management Landscape Continues to Evolve: Progress in Practice

Atlanta

Guy Young, MD
Children's Hospital Los Angeles
University of Southern California Keck School of Medicine
Los Angeles, California

December
8
Friday
6:00PM

Acute Lymphoblastic Leukemia

Redefining Patient Care in Acute Lymphoblastic Leukemia: The Impact of Novel Antibody and Immune Technologies on Clinical Outcomes

Atlanta

Daniel J. DeAngelo, MD, PhD
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts

December
8
Friday
12:30PM

Acute Myeloid Leukemia

A Master Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options

Atlanta

Harry P. Erba, MD, PhD
University of Alabama at Birmingham
Birmingham, Alabama

December
8
Friday
1:00PM

Acute Myeloid Leukemia

A Master Class on Building Better Therapy for AML: Making the Most of an Increasing Number of Innovative Options

Webcast

Harry P. Erba, MD, PhD
University of Alabama at Birmingham
Birmingham, Alabama

December
8
Friday
12:30PM

Myeloproliferative Neoplasms

Stories From the MPN Casebook: Expert Perspectives on Challenging Treatment Decisions in Polycythemia Vera and Myelofibrosis

Atlanta

Ruben A. Mesa, MD, FACP
Mayo Clinic in Arizona
Phoenix, Arizona

November
10
Friday
12:15PM

Lung Cancer

Addressing Unmet Needs in Lung Cancer With Rational Immunotherapy-Based Approaches: Evidence and Practicalities

National Harbor, MD

Naiyer Rizvi, MD
Columbia University Medical Center
New York, New York

November
8
Wed
3:00PM

Soft Tissue Sarcoma

Contemporary Management Strategies in STS: Targeted and Cytotoxic Treatment Options to Optimize Patient Outcomes

Wailea, HI

Robin L. Jones, MD
Royal Marsden Hospital and Institute of Cancer Research
London, United Kingdom

October
31
Tuesday
7:00 PM

Obesity Management

Navigating the Challenges in Obesity Management: Best Approaches to Engage the Patient and Personalize Care

National Harbor

Ken Fujioka, MD
Scripps Clinic
San Diego, California

October
30
Monday
5:30AM

Interstitial Lung Diseases

Deciphering the Difference Between Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases: Accurate Diagnosis and Optimal Therapy

Toronto

Kevin R. Flaherty, MD, MS
University of Michigan Health System
Ann Arbor, Michigan

October
28
Saturday
6:00PM

Oncologic Emergencies

Oncologic Emergencies in the ED: Recognizing and Managing Adverse Reactions Associated With Modern Cancer Therapies - Essential Guidance for Emergency Medicine Specialists

Washington, DC

Daniel Pallin, MD, MPH
Harvard Medical School
Brigham and Women's Hospital
Boston, Massachusetts

October
21
Saturday
7:30PM

Hepatocellular Carcinoma

The Expanding Role of the Hepatologist in Interdisciplinary Hepatocellular Carcinoma Management: Achieving the Full Potential of Targeted Therapy and Immunotherapy Advances

Washington, DC

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
New York, New York

October
9
Monday
6:30PM

Cancer Immunotherapy Biomarkers

The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists

National Harbor, MD

David L. Rimm, MD, PhD
Yale University School of Medicine
New Haven, Connecticut

October
9
Monday
7:00PM

Cancer Immunotherapy Biomarkers

The Present and the Future of Cancer Immunotherapy Biomarkers: Challenges, Opportunities, and Implications for Pathologists

Webcast

David L. Rimm, MD, PhD
Yale University School of Medicine
New Haven, Connecticut

October
6
Friday
7:00PM

Cytomegalovirus

CMV in the Transplant Recipient
At the Crossroads of Current Clinical Challenges and Novel Therapeutic Strategies

San Diego

Michael Boeckh, MD, PhD
Fred Hutchinson Cancer Research Center
University of Washington
Seattle, Washington

September
26
Tuesday
6:15PM

Head and Neck Cancer

Understanding the Impact of Immunotherapy on Head and Neck Cancer: A Look at the Science, Practice, and Future of Multimodal Treatment

San Diego

Robert L. Ferris, MD, PhD
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania

September
26
Tuesday
6:15PM

Head and Neck Cancer

Understanding the Impact of Immunotherapy on Head and Neck Cancer: A Look at the Science, Practice, and Future of Multimodal Treatment

Webcast

Robert L. Ferris, MD, PhD
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania

September
24
Sunday
6:15PM
September
16
Saturday
12:00PM

Heart Failure

Master Class on Heart Failure:
Implementing Real-World Experience and New Advances to Reduce Hospitalizations and Costs

Grapevine, Texas

Javed Butler, MD, MBA, MPH
Heart Institute
Stony Brook University
Stony Brook, New York

September
16
Saturday
6:30AM

Lung Cancer

New Options and Evolving Strategies for Hitting the Target in EGFR-Mutant NSCLC: Navigating the Transitions in the EGFR TKI Treatment Landscape in the Era of Precision Oncology

Chicago

Lecia V. Sequist, MD, MPH
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts